Literature DB >> 30167449

A case of subungual tumors of incontinentia pigmenti: A rare manifestation and association with bipolar disease.

Nour Kibbi1, Mariam Totonchy1, Kathleen C Suozzi1, Christine J Ko1, Ian D Odell1.   

Abstract

Entities:  

Keywords:  Bloch-Sulzberger syndrome; IKBKG; IP, incontinentia pigmenti; NEMO; NF-kappa-B; NF-κB, nuclear factor-κB; STIPs, subungual tumors of incontinentia pigmenti; bipolar disorder; genodermatosis; incontinentia pigmenti; lines of Blaschko; psychiatric disease; subungual tumors of incontinentia pigmenti

Year:  2018        PMID: 30167449      PMCID: PMC6113656          DOI: 10.1016/j.jdcr.2018.03.018

Source DB:  PubMed          Journal:  JAAD Case Rep        ISSN: 2352-5126


× No keyword cloud information.

Introduction

Incontinentia pigmenti (IP), or Bloch-Sulzberger syndrome, is an X-linked dominant disorder with male lethality caused by mutations in the IKBKG gene (also known as IKK-γ or NEMO), which is essential for nuclear factor-κB (NF-κB) activation and protects cells against tumor necrosis factor-α–induced apoptosis. In addition to the 4 cutaneous stages of IP (vesiculo-bullous, verrucous, hyperpigmented, and atrophic/hypopigmented), IP is also associated with ectodermal abnormalities, such as pegged teeth, alopecia, and anodontia as well as neurologic and ocular abnormalities. We present a family in which the mother has severe bipolar disorder and subungual tumors of incontinentia pigmenti (STIPs), and the daughter has classic clinical findings of IP.

Report of a case

A 25-year-old pregnant woman presented with tender subungual hyperkeratotic papules involving all her fingernails and 3 of 10 toenails (Fig 1, A). The lesions were present for more than 10 years, and her medical history was remarkable for longstanding symptoms of severe bipolar disorder, which was diagnosed 1 year earlier and treated with aripiprazole and trazodone. Three months after her initial visit, she delivered a healthy girl, who on day 13 of life, had dozens of 0.2-cm vesicles on the right arm in a Blaschkolinear distribution. At 5 weeks, the lesions evolved into 0.5- to 1-cm verrucous papules. Family history was remarkable for depression and similar, but milder, subungual hyperkeratotic papules in the presenting patient's mother. The patient's sister had a history of polysubstance abuse and schizophrenia but did not have any skin abnormalities.
Fig 1

Clinical and histopathologic presentation. A, Multiple tender, subungual hyperkeratotic verrucous papulonodules on all fingernails. B, Invaginating, hyperplastic epithelium composed of large, eosinophilic keratinocytes with scattered dyskeratotic cells (Hematoxylin-eosin stain; original magnification: ×4.)

Clinical and histopathologic presentation. A, Multiple tender, subungual hyperkeratotic verrucous papulonodules on all fingernails. B, Invaginating, hyperplastic epithelium composed of large, eosinophilic keratinocytes with scattered dyskeratotic cells (Hematoxylin-eosin stain; original magnification: ×4.) The development of vesicular then verrucous lesions along Blaschko lines fulfilled 3 major criteria for diagnosis of IP in the daughter. Additional history and physical examination of the mother found a history of male stillbirth, multiple peg-shaped teeth, and a 12-cm Blaschkolinear, hypopigmented, atrophic plaque with follicular dropout on the left calf, which were also clinically diagnostic of IP. She had no history of alopecia or ocular abnormalities. Biopsy of the mother's subungual lesions showed invaginating, hyperplastic epithelium composed of large, eosinophilic keratinocytes with scattered dyskeratotic cells (Fig 1, B). Human papilloma virus immunostain and periodic acidSchiff stain were both negative. Plain radiographs of the mother's hands showed lucencies in the distal phalanges of the first through fourth fingers bilaterally, with adjacent soft tissue swelling. The clinical findings fulfilled the diagnostic criteria for IP and the initial presenting complaint represented STIPs. Confirmatory genetic testing in both mother and child showed deletion in exons 4-10 in IKBKG, the mutation present in 80% to 90% of cases of IP. Treatment of the mother's STIPs included cryotherapy, salicylic acid, and tazarotene 0.1% gel without significant improvement. She was unable to comply with isotretinoin therapy because of her emotional lability requiring inpatient psychiatric admission for 2 months, so ultimately, she underwent excision of her nailbed tumors by plastic surgery, which she tolerated well.

Discussion

First reported in 1966, STIPs are rare painful subungual hyperkeratotic lesions that occur after puberty in patients with IP. There are at least 20 reported cases of STIPs to date, outlined in Table I.3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18 All patients were female, and in 60% of them, IP was not diagnosed until later in life. Forty-five percent of cases underwent confirmatory genetic testing, and the onset of STIPs typically was 24 years of age. However, diagnosis of STIPs or IP was often delayed by an additional 10 years. More than half of STIP cases were initially misdiagnosed as paronychia, verruca, keratoacanthoma, squamous cell carcinoma, or epidermoid cysts. Pathology findings of STIPs showed dyskeratosis (12 of 15), hyperkeratosis (10 of 15), and hypergranulosis (7 of 15). Similar to the verrucous stage of IP, pseudoepitheliomatous hyperplasia (5 of 15) and parakeratosis (4 of 15) were also reported. STIPs rarely resolve on their own; however, resolution during pregnancy has been reported.3, 4 Treatment includes surgical excision4, 16 and, more recently, oral12, 15 and topical retinoids.
Table I

Reported cases of STIPs

StudyGender, age at classic IPIP suspected at birthGenetic testingAge at first STIP (y)MisdiagnosesDelay in diagnosis (y)Radiographic findingsHistopathologyTreatment
Hartman,3 1966F, birthNoNo20Verruca, epidermal cyst10YesDyskeratosis, hyperkeratosis, hypergranulosis, parakeratosis, PEHSpontaneous regression with pregnancy
Pinol et al,5 1973F, infancyNoNo15n/an/an/aHyperkeratosis, hypergranulosis, parakeratosis, pyknotic nucleiElectrocautery
Pinol et al,5 1973F, infancyNoNo16n/an/aNoneHyperkeratosis, hypergranulosis, parakeratosis, pyknotic nucleiSurgical excision
Mascaro et al,6 1985F, birthNoNo23n/a5YesDyskeratosis, hyperkeratosis, hypergranulosis, PEHSurgical excision
Hermanns and Piérard,7 1986F, birthn/aNo16n/an/an/an/an/a
Simmons et al,8 1986F, birthNoNo22n/a3YesDyskeratosis, hyperkeratosis, parakeratosis, PEH, acanthosis, papillomatosisElectrodessication and curettage
Moss and Ince,9 1987F, n/an/aNo22n/a0.4n/an/aSpontaneous resolution
Adeniran et al,10 1993F, birthNoNo25Chronic paronychia, KA, verruca4YesHyperkeratosis, hypergranulosis with irregular acanthosis, parakeratosis, nonspecific infiltrate in dermisSurgical excision
Abimelec et al,11 1995F, birthYesNo10Verrucan/aNoneFocal dyskeratosis with whorled pattern, hyperkeratosis with parakeratosis, papillomatosis, lymphohistiocytic infiltrate in upper dermis2% fluorouracil + betamethasone diproprionate-3% salicylic acid
Malvehy et al,12 1998F, n/aYesNon/an/an/aYesDyskeratosis, hyperkeratosis, hypergranulosis, PEHEtretinate, 1 mg/kg x 6 mo with resolution
Nicolaou et al,13 2003F, n/aNoYes11n/a46n/an/aAresenic; radiotherapy; antifungals, topical steroids
Montes et al,4 2004F, birthNoYes25Verruca, KA, callus, SCC29YesDyskeratosis, acanthosis, papillomatosisSurgical excision; topical treatments (not specified); spontaneous regression
Montes et al,4 2004F, birthYesYes18Epidermal inclusion cyst,verruca0No abnormalitiesDyskeratosis, hyperkeratosis, epidermal hyperplasiasurgical excision; spontaneous regression
Bittar et al,14 2005F, n/aNoYes45Lichen planus2n/an/an/a
F, n/aNoYes40n/a5n/an/an/a
Young et al,15 2005F, birthYes/infancyYes25Verruca, SCC treated with amputationn/aYesDyskeratosis, PEH, keratinizing epithelium with cystic structuresAcitretin, 25 mg/d x2 mo
Donati et al,16 2009F, birthNoYes28Squamous neoplasia3n/aDyskeratosis, hypergranulosis, PEH, acanthosisRetinoic acid 0.05% cream BID x6 months
Lamb et al,17 2012F, birthYes/infancyNo27Paronychia, SCC resulting in thumb tip amputationn/aYesDyskeratosis, PEHSurgical excision with resolution; acitretin, 50 mg/d + topical isotretinoin 0.05% gel without response
Mahmoud et al,18 2014F, birthYesYes30Verruca, SCC resulting in left third fingertip amputation10YesDyskeratosis, hyperkeratosis, PEHn/a
Current caseF, n/aNoYes15Verruca10YesSubungual keratin and parakeratin with dyskeratotic cellsSalicylic acid 27.5% daily. Tazarotene 0.1% gel; referral to plastic surgery for excision

Note: Delay in diagnosis refers to the time between appearance of the first STIP and arrival at the correct diagnosis.

IP, Incontinentia pigmenti; KA, keratoacanthoma; n/a, not available; NF-κβ: nuclear factor-κβ; PEH, pseudoepitheliomatous hyperplasia; SCC, squamous cell carcinoma; STIPs, subungual tumors of incontinentia pigmenti.

Reported cases of STIPs Note: Delay in diagnosis refers to the time between appearance of the first STIP and arrival at the correct diagnosis. IP, Incontinentia pigmenti; KA, keratoacanthoma; n/a, not available; NF-κβ: nuclear factor-κβ; PEH, pseudoepitheliomatous hyperplasia; SCC, squamous cell carcinoma; STIPs, subungual tumors of incontinentia pigmenti. In addition to her STIPs, our patient had a long history of severe bipolar disorder. The association of IP with psychiatric disease has not been previously described to our knowledge. The chromosomal location of IKBKG is on Xq28. Association of bipolar disorder with coagulation factor IX and fragile X syndrome previously suggested susceptibility to effective disorders in the same chromosomal region, although a specific causative gene was not identified. There is accumulating evidence for a role of the immune system in psychiatric diseases including schizophrenia and bipolar disorder, and there is correlative evidence for NF-kB activation in bipolar disorder. As observed in keratinocytes in the skin, the inability to activate NF-kB in IKBKG-deficient neurons likely increases their susceptibility to apoptosis. However, a direct causal relationship between IKBKG deficiency on NF-kB signaling and the neuronal abnormalities in bipolar disorder is yet to be elucidated. In summary, we present a case of IP with associated painful subungual tumors and severe bipolar disease, the pathogenesis of which may relate to loss of the neuroprotective effects of NF-κB.
  20 in total

1.  Painful subungal dyskeratotic tumors in incontinentia pigmenti.

Authors:  Alison Young; Pamela Manolson; Benard Cohen; Mitchell Klapper; Terry Barrett
Journal:  J Am Acad Dermatol       Date:  2005-04       Impact factor: 11.527

2.  Late-onset familial onychodystrophy heralding incontinentia pigmenti.

Authors:  Mario Bittar; Retno Danarti; Arne König; Andreas Gal; Rudolf Happle
Journal:  Acta Derm Venereol       Date:  2005       Impact factor: 4.437

3.  Painful subungual tumour in incontinentia pigmenti. Response to treatment with etretinate.

Authors:  J Malvehy; J Palou; J M Mascaró
Journal:  Br J Dermatol       Date:  1998-03       Impact factor: 9.302

4.  Controversies over subungual tumors in incontinentia pigmenti.

Authors:  Bassel H Mahmoud; Artur Zembowicz; Emily Fisher
Journal:  Dermatol Surg       Date:  2014-10       Impact factor: 3.398

5.  Subungual tumors in incontinentia pigmenti.

Authors:  D A Simmons; M F Kegel; R K Scher; Y C Hines
Journal:  Arch Dermatol       Date:  1986-12

6.  Bipolar spectrum disorder and fragile X syndrome: a family study.

Authors:  F M Jeffries; A L Reiss; W T Brown; D A Meyers; A C Glicksman; S Bandyopadhyay
Journal:  Biol Psychiatry       Date:  1993-02-01       Impact factor: 13.382

7.  Incontinentia pigmenti associated with subungual tumors.

Authors:  D L Hartman
Journal:  Arch Dermatol       Date:  1966-11

8.  Nail dystrophy, an unusual presentation of incontinentia pigmenti.

Authors:  N Nicolaou; R A C Graham-Brown
Journal:  Br J Dermatol       Date:  2003-12       Impact factor: 9.302

9.  A recurrent deletion in the ubiquitously expressed NEMO (IKK-gamma) gene accounts for the vast majority of incontinentia pigmenti mutations.

Authors:  S Aradhya; H Woffendin; T Jakins; T Bardaro; T Esposito; A Smahi; C Shaw; M Levy; A Munnich; M D'Urso; R A Lewis; S Kenwrick; D L Nelson
Journal:  Hum Mol Genet       Date:  2001-09-15       Impact factor: 6.150

Review 10.  The Emerging Neurobiology of Bipolar Disorder.

Authors:  Paul J Harrison; John R Geddes; Elizabeth M Tunbridge
Journal:  Trends Neurosci       Date:  2017-11-20       Impact factor: 13.837

View more
  1 in total

1.  Beta HPV Type 15 Can Interfere With NF-κB Activity and Apoptosis in Human Keratinocytes.

Authors:  Francesca Paolini; Marco Zaccarini; Arianna Francesconi; Luciano Mariani; Luca Muscardin; Pietro Donati; Aldo Venuti
Journal:  Front Cell Infect Microbiol       Date:  2020-03-18       Impact factor: 5.293

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.